Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference
Presentation by Dr. Miriam Kidron, Chief Scientific Officer Date: Tuesday, March 28, 2017 Time: 10:45 a.m. EST Location: Royal Sonesta Boston, Cambridge, MA
Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017
JERUSALEM, March 22, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Dr. Miriam Kidron, Oramed’s Chief Scientific Officer, will deliver a presentation titled, “Oral Insulin for Diabetes Treatment: Bypassing the Roadblock,” at the upcoming Cambridge Healthtech Institute’s Oligonucleotide and […]
